Search

Search Constraints

You searched for: Author/Creator Diverio, Daniela

Search Results

1. Arsenic trioxide and all‐trans retinoic acid treatment for childhood acute promyelocytic leukaemia. (20th July 2018)

2. Body mass index does not impact on molecular response rate of chronic myeloid leukaemia patients treated frontline with second generation tyrosine kinase inhibitors. (5th July 2017)

3. Can chronic myeloid leukaemia in children and adolescents be successfully treated without haematopoietic stem cell transplant? A single centre experience. (23rd February 2016)

4. Chronic phase chronic myeloid leukemia patients who failed interferon alpha and switched to imatinib: Long‐term 9‐year follow‐up of 134 patients. Issue 5 (30th March 2015)

5. Clinical results according to age in patients with chronic myeloid leukemia receiving imatinib frontline: The younger, the later, the worse?. (19th September 2018)

6. Digital droplet PCR as a predictive tool for successful discontinuation outcome in chronic myeloid leukemia: Is it time to introduce it in the clinical practice?. (January 2021)

7. Discontinuation of alpha-interferon treatment in patients with chronic myeloid leukemia in long-lasting complete molecular response. Issue 1 (2nd January 2016)

8. Early response does not predict outcome in children and adolescents with chronic myeloid leukaemia treated with high‐dose imatinib. (16th December 2016)

9. Impact of exclusion criteria for the DASISION and ENESTnd trials in the front‐line treatment of a 'real‐life' patient population with chronic myeloid leukaemia. Issue 2 (9th December 2015)

10. Independent prognostic impact of CD15 on complete remission achievement in patients with acute myeloid leukemia. Issue 4 (12th July 2016)